Get started
InnoCan Pharma CorporationInnoCan Pharma CorporationInnoCan Pharma Corporation

InnoCan Pharma Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions

IP40 chart


Full chart

Key stats


Market capitalization
‪34.21 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.31 EUR
Net income (FY)
‪−1.69 M‬ EUR
Revenue (FY)
‪27.07 M‬ EUR
Shares float
‪3.44 M‬
Beta (1Y)
0.22

About InnoCan Pharma Corporation


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Iris Or Gabi Bincovich
Website
innocanpharma.com
Headquarters
Calgary
Founded
2018
ISIN
CA45783P5085
FIGI
BBG00SXHX1K3
InnoCan Pharma Corp. operates as a pharmaceutical tech company. It operates through the Online Sales and Other Operations segments. The Online Sales segment engages in the development of non-CBD personal care and beauty products in the United States for online platforms such as Amazon, and other e-commerce retail sales. The Other Operations segment involves in the development of several drug delivery platforms, combining cannabinoids with other pharmaceutical ingredients as well as the development and sale of CBD-integrated topical products. The company was founded in October 2017 and is headquartered in Alberta, Canada.

Check out other big names from the same industry as IP40.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

IP40 news



Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange InnoCan Pharma Corporation stocks are traded under the ticker IP40.
Yes, you can track InnoCan Pharma Corporation financials in yearly and quarterly reports right on TradingView.
IP40 net income for the last quarter is ‪−509.11 K‬ EUR, while the quarter before that showed ‪−536.34 K‬ EUR of net income which accounts for 5.08% change. Track more InnoCan Pharma Corporation financial stats to get the full picture.
No, IP40 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. InnoCan Pharma Corporation EBITDA is ‪306.82 K‬ EUR, and current EBITDA margin is −4.12%. See more stats in InnoCan Pharma Corporation financial statements.
Like other stocks, IP40 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InnoCan Pharma Corporation stock right from TradingView charts — choose your broker and connect to your account.